"Urogenital Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Descriptor ID |
D014565
|
| MeSH Number(s) |
C04.588.945 C12.758 C13.351.937
|
| Concept/Terms |
Urogenital Neoplasms- Urogenital Neoplasms
- Neoplasm, Urogenital
- Urogenital Neoplasm
- Neoplasms, Urogenital
- Genito-urinary Neoplasm
- Genito-urinary Neoplasms
- Neoplasm, Genito-urinary
- Neoplasms, Genito-urinary
- Genitourinary Neoplasms
- Genitourinary Neoplasm
- Neoplasm, Genitourinary
- Neoplasms, Genitourinary
Genitourinary Cancer- Genitourinary Cancer
- Cancer, Genitourinary
- Cancers, Genitourinary
- Genitourinary Cancers
- Genito-urinary Cancer
- Cancer, Genito-urinary
- Cancers, Genito-urinary
- Genito urinary Cancer
- Genito-urinary Cancers
- Urogenital Cancer
- Cancer, Urogenital
- Cancers, Urogenital
- Urogenital Cancers
|
Below are MeSH descriptors whose meaning is more general than "Urogenital Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urogenital Neoplasms".
This graph shows the total number of publications written about "Urogenital Neoplasms" by people in this website by year, and whether "Urogenital Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 0 | 3 | 3 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2020 | 4 | 0 | 4 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Urogenital Neoplasms" by people in Profiles.
-
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. J Clin Oncol. 2024 Sep 01; 42(25):3033-3046.
-
Distinct CT imaging features of new liver metastases from primary genitourinary cancers. Abdom Radiol (NY). 2024 Jul; 49(7):2209-2219.
-
Novel and Emerging Concepts in Genitourinary Tumors Empowered in the Multidisciplinary and Molecular Era. Adv Anat Pathol. 2024 May 01; 31(3):145-146.
-
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis. Oncologist. 2023 09 07; 28(9):e748-e755.
-
Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts. Mod Pathol. 2021 06; 34(6):1203-1212.
-
Targetable gene fusions and aberrations in genitourinary oncology. Nat Rev Urol. 2020 11; 17(11):613-625.
-
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors. J Clin Oncol. 2020 11 01; 38(31):3672-3684.
-
The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future. Eur Urol. 2020 11; 78(5):731-742.
-
Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data. JCO Clin Cancer Inform. 2020 07; 4:614-622.
-
Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urol Oncol. 2017 07; 35(7):473-491.